MARKHAM, ON, June 16, 2017 /CNW/ - MedReleaf Corp. (TSX: LEAF), Canada's first and only ISO 9001 certified cannabis producer, today announced that it will hold a conference call to discuss its fourth quarter and fiscal year 2017 results on Wednesday, June 28, 2017 at 8:00 a.m. (ET). The call will be hosted by Neil Closner, Chief Executive Officer, and Igor Gimelshtein, Chief Financial Officer, followed by a question and answer period. MedReleaf will report its financial results in the morning prior to the call.
Fourth Quarter and Fiscal Year 2017 Conference Call Details:
| Date: | Wednesday, June 28, 2017 |
| Time: | 8:00 a.m. (ET) |
| Dial in number: | (647) 427-7450 or 1-888-231-8191 |
| Live webcast: | https://bit.ly/2rl9jgz Webcast will be archived for 90 days |
| Replay: | 1-855-859-2056 Available until July 5, 2017 |
| Replay passcode: | 41045544 |
About MedReleaf Corp.
MedReleaf sets The Medical Grade Standard™ for cannabis in Canada and around the world. The first and only ISO 9001 certified cannabis producer in North America, MedReleaf is a R&D-driven company dedicated to patient care, scientific innovation, research and advancing the understanding of the therapeutic benefits of cannabis. Sourced from around the world and perfected in one of two state of the art facilities in Ontario, MedReleaf delivers a variety of premium products to patients seeking safe, consistent and effective medical cannabis.
For more information on MedReleaf, its products, research and how the company is helping patients #livefree, please visit MedReleaf.com or follow @medreleafcanada
SOURCE MedReleaf Corp.
Dennis Fong, Investor Relations, investorrelations@medreleaf.com, (416) 283-9930